boxed warning , the most serious type of warning from the Food and Drug Administration (FDA)
KPV introduces additional considerations
This is where novel weight loss peptides become a necessary consideration for comprehensive medical weight loss programs
To date, all these peptides have followed similar trajectories: promising animal data with no evidence of efficacy in humans, despite extensive advertising and widespread availability of these compounds to athletes, Ellis and colleagues wrote in their AOSSM article
By Donna Monthei, RDN, LD | Originally Published: May 7, 2025 | Medically Reviewed on June 18, 2026 First things first, lets do a quick recap on what these GLP-1 (glucagon-like peptide-1) receptor agonists actually do
A.BakkerM.van der HeijdenA